- CORRESPONDENCE
Data sharing: putting Nature’s policy to the test
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 619, 698 (2023)
doi: https://doi.org/10.1038/d41586-023-02250-z
The reproducibility/verification analyses of published results reported in this Correspondence were funded in part by the National Institutes of Health (NIH) grants. The opinions expressed are those of the authors and not necessarily of the NIH.
Competing Interests
In the past 36 months, D.B.A. has received personal payments or promises for same from: Alkermes, Inc.; Amin Talati Wasserman for KSF Acquisition Corp (Glanbia); Clark Hill PLC; Kaleido Biosciences; Law Offices of Ronald Marron; Medpace/Gelesis; Novo Nordisk Fonden; Sports Research Corp.; and Zero Longevity Science (as stock options).